Mr Ali Pashazadeh is Founder, Chairman and CEO of Treehill Partners. He is an experienced healthcare investment banker, biotech CEO, and trained surgeon with significant expertise across the healthcare value chain.
At Treehill, Ali is ultimately accountable for delivery of client value on all our engagements. He is involved as senior sponsor in a majority of projects and available to clients for strategic and tactical advice.
He puts to work a synthesis of strategic expertise, cross-functional insight, and deep hands-on medical understanding when advising clients on their core strategies.
Prior to founding Treehill, Ali was at The Blackstone Group leading the global Healthcare team of Blackstone Advisory Partners.
Prior to Blackstone, Ali worked at UBS Investment Bank, leading the European biotech coverage.
He completed M&A and financing assignments worth above $40 billion, including various landmark transactions in the pharma and biotech sector.
Ali holds a Master of Business Administration from London Business School, an MBBS and BSc from St. Mary’s Hospital Medical School, and is a Member of the Royal College of Surgeons (MRCS).